default author photo

Wenying Yu

China Pharmaceutical University - Institute of Pharmaceutical Sciences

Nanjing

China

  • China Pharmaceutical University - Institute of Pharmaceutical Sciences

SCHOLARLY PAPERS

4

DOWNLOADS

282

TOTAL CITATIONS

0

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Reactogenicity and Immunogenicity of Heterologous ChAdOx1-nCoV19 and BNT162b2 Vaccination: A Systematic Review and Meta-Analysis of the Heterologous COVID-19 Vaccination Outcomes

Number of pages: 33 Posted: 13 Sep 2021
Yuxuan Hu, Yanning Wang, Taihang Shao, Wenxi Tang, Kejin Hu, Kerong Hu, Yujie Zhou, Liyun Miao, Jing Liu, Bin Wang and Wenying Yu
China Pharmaceutical University - Institute of Pharmaceutical Sciences, Nanjing University - Clinical Stem Cell Center, China Pharmaceutical University - Department of Pharmacoeconomics, China Pharmaceutical University - Department of Pharmacoeconomics, University of Alabama at Birmingham - Department of Biochemistry and Molecular Genetics, Huangshi Love & Health Hospital - Department of Infectious Diseases, Nanjing University - Department of Respiratory and Critical Care Medicine, Nanjing University - Department of Respiratory Medicine, Nanjing Yuhua Hospital (Yuhua Branch of Nanjing First Hospital) - Clinical Laboratory, Nanjing University - Clinical Stem Cell Center and China Pharmaceutical University - Institute of Pharmaceutical Sciences
Downloads 89 (747,755)

Abstract:

Loading...

COVID-19, SARS-CoV-2, heterologous vaccination, immunogenicity, meta-analysis

2.

Efficacy and Safety of First-Line Therapeutic Drugs with Potential for the Treatment of Novel Coronavirus Pneumonia: A Meta-Analysis

Number of pages: 27 Posted: 04 Aug 2020
Yuxuan Hu, Yang Li, Fan Jiang, Taihang Shao, Bing Hu, Jiawen Zhu, Chong Lai and Wenying Yu
China Pharmaceutical University - School of International Pharmaceutical Business, School of International Pharmaceutical Business, China Pharmaceutical University, School of International Pharmaceutical Business, China Pharmaceutical University, China Pharmaceutical University - Department of Pharmacoeconomics, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, China Pharmaceutical University - State Key Laboratory of Natural Medicines, Zhejiang University - Department of Urology and China Pharmaceutical University - Institute of Pharmaceutical Sciences
Downloads 87 (759,537)

Abstract:

Loading...

3.

Discovery of Novel Pyridine Skeleton Derivatives as Potent Clk2/3 Inhibitors

Number of pages: 18 Posted: 28 Oct 2024
Jie Wei, GuoChuang Zheng, TingTing Yu, Qi Liu, Wenying Yu, Cheng Jiang and Xu Quan
China Pharmaceutical University, affiliation not provided to SSRN, China Pharmaceutical University, affiliation not provided to SSRN, China Pharmaceutical University - Institute of Pharmaceutical Sciences, China Pharmaceutical University and affiliation not provided to SSRN
Downloads 53 (1,031,043)

Abstract:

Loading...

CLK2, CLK3, inhibitor，small molecule

4.

Triple Gene Detection of CALR, JAK2(V617F) or MPL(W515L/K) Mutation to Predict Thrombosis and Splenomegaly Risk in Essential Thrombocythemia and Primary Myelofibrosis Patients: A Systematic Review and Meta-Analysis

Number of pages: 19 Posted: 02 Oct 2020
Jiawen Zhu, Yang Li, Yuxuan Hu, Jian Hong, Yanwen Liu, Pinjiang Han, Shuyun Zheng and Wenying Yu
China Pharmaceutical University - State Key Laboratory of Natural Medicines, China Pharmaceutical University - School of International Pharmaceutical Business, China Pharmaceutical University - School of International Pharmaceutical Business, Nanjing Medical University - Department of Geriatric Cardiology, Southeast University - Department of Oncology, Lianshui County People’s Hospital - Department of Clinical Laboratory, Jiangsu Cancer Hospital - Department of Critical Care Medicine and China Pharmaceutical University - Institute of Pharmaceutical Sciences
Downloads 53 (1,031,043)

Abstract:

Loading...